| 名稱 | AI-Edigene® EML4(E18)-ALK(E20) V2 Fusion |
| 型號 | CBP20196R |
| 報價 |  |
| 特點 | AI-Edigene® EML4(E18)-ALK(E20) V2 Fusion |
產品搜索
相關文章
聯系我們
產品展示 / PRODUCTS
- 詳細內容
| CBP20196R |
| Format | RNA |
| Description | EML4-ALK results from the fusion of EML4 and ALK, resulting in constitutive kinase activity, transformation in cultured cells, and tumor activity in mouse models (PMID: 19064915, PMID: 17625570). EML4-ALK fusions have been associated with non-small cell lung cancer (PMID: 26755435). |
| Technical Data | |
| Left Gene | EML4 |
| Left Breakpoint | chr2:42543844:+ |
| Right Gene | ALK |
| Right Breakpoint | chr2:29446566:- |
| Cosmic ID | COSF488 |
| Buffer | RNase-free H2O |
| Product Information | |
| Intended Use | Research Use Only |
| Unit Size | 1ug |
| Concentration | Download for COA |
| Purity | Download for COA |
| RNA electrophoresis | Download for COA |
| Sanger sequencing | Download for COA |
| Storage | -80℃ |
| Expiry | 12 months from the date of manufacture |
